Cargando…

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies

OBJECTIVES— Recently, an association was found between diabetic nephropathy and the D18S880 microsatellite, located in the carnosinase gene (CNDP1) on chromosome 18q. Alleles of this microsatellite encode for a variable number of leucine residues (from four to seven) in the leader peptide of the car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wanic, Krzysztof, Placha, Grzegorz, Dunn, Jonathon, Smiles, Adam, Warram, James H., Krolewski, Andrzej S.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2008
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518509/ https://www.ncbi.nlm.nih.gov/pubmed/18753673 http://dx.doi.org/10.2337/db07-1303

Ejemplares similares

Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease
por: Rodriguez-Niño, Angelica, et al.
Publicado: (2019)

Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
por: Mooyaart, Antien L., et al.
Publicado: (2010)

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
por: Alkhalaf, A., et al.
Publicado: (2010)

High-Density Single Nucleotide Polymorphism Genome-Wide Linkage Scan for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes: Discordant Sibpair Approach
por: Rogus, John J., et al.
Publicado: (2008)

The CNDP1 (CTG)(5) Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration
por: Albrecht, Thomas, et al.
Publicado: (2017)

Association of CTG repeat polymorphism in carnosine dipeptidase 1 (CNDP1) gene with diabetic nephropathy in north Indians
por: Yadav, Ashok K., et al.
Publicado: (2016)

The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes
por: Kurashige, Mahiro, et al.
Publicado: (2013)

CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia
por: Yahya, Mohd Jokha, et al.
Publicado: (2019)

The (CTG)(n) repeat polymorphism in CNDP1 gene: new insights into an old molecule
por: Santos, Kátia G.
Publicado: (2016)

Up-regulation of CNDP2 facilitates the proliferation of colon cancer
por: Xue, Conglong, et al.
Publicado: (2014)

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline
por: Wanic, Krzysztof, et al.
Publicado: (2013)

Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes
por: Pezzolesi, Marcus G., et al.
Publicado: (2009)

Genotype Distribution of CNDP1 Polymorphisms in the Healthy Chinese Han Population: Association with HbA1c and Fasting Blood Glucose
por: Zhang, Shiqi, et al.
Publicado: (2020)

MEA-CNDP: A Membrane Evolutionary Algorithm for Solving Biobjective Critical Node Detection Problem
por: Xu, Yaochang, et al.
Publicado: (2021)

Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections
por: Bramer, Lisa M., et al.
Publicado: (2023)

A Global Cndp1-Knock-Out Selectively Increases Renal Carnosine and Anserine Concentrations in an Age- and Gender-Specific Manner in Mice
por: Weigand, Tim, et al.
Publicado: (2020)

CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
por: Zhang, Li Q., et al.
Publicado: (2019)

A toolset to study functions of Cytosolic non-specific dipeptidase 2 (CNDP2) using Drosophila as a model organism
por: Andreyeva, Evgeniya N., et al.
Publicado: (2019)

Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy
por: Pezzolesi, Marcus G., et al.
Publicado: (2013)

Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients
por: Zhou, Zhou, et al.
Publicado: (2021)

Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
por: Krolewski, Andrzej S.
Publicado: (2015)

Astragaloside IV Attenuates Programmed Death-Ligand 1-Mediated Immunosuppression during Liver Cancer Development via the miR-135b-5p/CNDP1 Axis
por: Ma, Yang, et al.
Publicado: (2023)

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes
por: Perkins, Bruce A., et al.
Publicado: (2012)

Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes
por: Nowak, Natalia, et al.
Publicado: (2016)

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease
por: Skupien, Jan, et al.
Publicado: (2012)

Carnosinases, Their Substrates and Diseases
por: Bellia, Francesco, et al.
Publicado: (2014)

Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Supports Its Role as a Susceptibility Gene in Diabetic Nephropathy
por: Pezzolesi, Marcus G., et al.
Publicado: (2009)

Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR(Ob/Ob) mice
por: Qiu, Jiedong, et al.
Publicado: (2020)

Carnosinase-1 Knock-Out Reduces Kidney Fibrosis in Type-1 Diabetic Mice on High Fat Diet
por: Pfeffer, Tilman, et al.
Publicado: (2023)

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
por: Ficociello, Linda H., et al.
Publicado: (2009)

Serum and urinary carnosinase-1 correlate with kidney function and inflammation
por: Zhang, Shiqi, et al.
Publicado: (2022)

Binding Modes of Carnostatine, Homocarnosine, and Ophidine to Human Carnosinase 1
por: Toviwek, Borvornwat, et al.
Publicado: (2023)

Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes
por: Pezzolesi, Marcus G., et al.
Publicado: (2015)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift
por: Peters, Verena, et al.
Publicado: (2017)

Association of Adiponectin Gene Polymorphisms With Type 2 Diabetes in an African American Population Enriched for Nephropathy
por: Bostrom, Meredith A., et al.
Publicado: (2009)

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria
por: Krolewski, Andrzej S., et al.
Publicado: (2014)

Brain type carnosinase in dementia: a pilot study
por: Balion, Cynthia M, et al.
Publicado: (2007)

Erythrocytes Prevent Degradation of Carnosine by Human Serum Carnosinase
por: Oppermann, Henry, et al.
Publicado: (2021)

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria
por: Skupien, Jan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2cq1mmld8ud2qi2a8hh49ucg3i